In these uncertain times, it is more important than ever to connect and share ideas. The Law Over Lunch series offers FDLI members the exclusive opportunity to engage in facilitated virtual discussions over lunch on topics of interest to the food and drug law community. The July event features unique and co-occurring discussion groups, limited to ten attendees to encourage fruitful conversation. This member-only benefit is a chance to closely learn from, educate, and network with other professionals in the field on new and pertinent topics.

Please only sign up for one discussion as they will take place at the same time.

Table Topics and Facilitators

Emergency Management During the COVID-19 Pandemic: How FDA Responds to an Emergency
Bob Durkin, Of Counsel, and Genevieve Razick, Associate
Arnall Golden Gregory LLP

Orphan Drugs: Interesting Cases and New Developments
Scott Lassman, Principal
Lassman Law + Policy

Dealing with Delays: Clinical Trials and Inspections Under COVID-19 
Veleka Peeples-Dyer, Chair, North America Food and Drug Practice; Principal, Litigation & Government Enforcement Practice Group
Baker & McKenzie LLP

Exploring the Boundaries Between Medical Foods and Dietary Supplements
Brooke Schumm, President and Principal
Daneker, McIntire, Schumm, Prince, Manning & Widmann, PC

July 30, 2020
12:00-1:00 PM

Registration is open to FDLI members only and is first come, first served.

This is a complimentary virtual event.

Register Now

Please only sign up for one discussion as they will take place at the same time.

For questions, please contact Claire Day.